TMO – Transplante de Medula Óssea
Amin Alousi – EUA
Amin M. Alousi, M.D. graduated from Wayne State University Medical School in 1997. He completed residencies in Internal Medicine and Pediatrics at Wayne State University (1997–2001), served as Chief Medical Resident at Detroit Receiving Hospital (2001-2002), and fellowships in Adult Hematology and Oncology at Karmanos Cancer Institute (2002-2005). In 2005 he came to MD Anderson Cancer Center to receive specialty training in Hematopoietic Stem Cell Transplantation (BMT). He was appointed Assistant Professor of Medicine at MD Anderson Cancer Center in 2005 where he specializes in the treatment of various hematologic malignancies. His primary field of research is in the prevention and treatment of graft versus host disease for which he is the principle investigator on numerous clinical trials. He also helps to establish guidelines at MD Anderson Cancer Center and nationally for “survivorship” needs for patients following allogeneic transplantation. In 2012 Dr. Alousi reached an important milestone in his career as he was promoted to Associate Professor of Medicine in the department of Stem Cell Transplantation and Cellular Therapy. He has published several papers and book chapters related to hematology, oncology and graft versus host disease; and serves as reviewer for various journals. He is board certified in Internal Medicine, Adult Hematology and Adult Oncology.
Daniel R. Couriel – EUA
Mary Flowers - EUA
Dr. Flowers is the Medical Director of the Posttransplant Long-term Follow-up Clinical Service at Fred Hutchinson Cancer Research Center (FHCRC) and the Seattle Cancer Care Alliance. She is a Member of the FHCRC and a Professor of Medicine at the University of Washington, Seattle, Washington, USA.
Marcos de Lima- EUA
Dr. Marcos de Lima is Director of Stem Cell Transplant and Hematologic Malignancies at the University Hospitals Cleveland Medical Center, and Professor of Medicine, Case Western Reserve University. He has extensive experience developing and conducting clinical trials in the context of hematopoietic stem cell transplantation for myeloid malignancies. His research focus on strategies to expand allogeneic transplantation to patients without HLA-identical siblings, in the treatment and prevention of leukemia relapse after transplant, and the improvement of conditioning regimens for transplant.
Robert Gale – Inglaterra
Robert Peter Gale is currently Visiting Professor of Haematology at the Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London; Honorary Professor of Hematology at the Institute of Hematology at Peking Union Medical College and on the Clinical Faculty at the University of California Los Angeles. Prof. Gale is also an expert on the medical response to nuclear and radiation accidents. He is also executive director of clinical research and development at Celgene Corporation and an honorary member of the Russian and Chinese Academies of Medical Science
Simrit Parmar – EUA
Dr. Simrit Parmar is an Associate Professor in the department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center, Houston, Texas. Her basic science research interest is focused on regulatory T cells, their involvement in disease pathogenesis and prevention of autoimmune disorders including graft versus Host Disease. Her clinical interest is in developing the comprehensive Amlyoidosis programs in collaboration with the department of Myeloma
Anton Hagenbeek – Holanda
Professor of Hematology
Academic Medical Center (AMC)
Dept of Hematology
University of Amsterdam
Amsterdam, the Netherlands
Hans-Jochem Kolb – Alemanha
Head of the Clinical Cooperative Group Haematopoietic Cell Transplantation Of University of Munich and Helmholtz Zentrum Muenchen
Retired as emeritus professor, Consultant of the Technical University of Munich
consultant at the Dep Pediatrics of the Technical University of Munich and at the Klinikum München Schwabing
Marcelo Pasquini – EUA
Ricardo Saccardi – Itália
Sérgio Giralt – EUA
Melvin Berlin Family Chair in Myeloma Research
Professor of Medicine
Weill Cornell Medical College
Chief Attending, Adult BMT Service
Memorial Sloan Kettering Cancer Center
Stefan Octavian Ciurea – EUA
Department of Stem Cell Transplantation and Cellular Therapy,
The University of Texas MD Anderson Cancer Center
HLA / Histocompatibility
Ana Hernandez – EUA
Director in Training
University of Miami
Eric Spierings – Holand
Dr. Spierings received his PhD degree as immunologist at the Leiden University Medical Center, The Netherlands. He is recognized as SMBWO Immunologist by the Dutch Society for Immunology and as Medical Immunologist by the College of Medical Immunologists. His postdoctoral training was performed on minor H antigens in organ- and stem-cell transplantation in the laboratory of Prof. Dr. Els Goulmy, Leiden, The Netherlands. In 2008, he was appointed as lab director of the HLA laboratory of the University Medical Centre Utrecht, The Netherlands. In that position, he combines diagnostic histocompatibility testing with research. His current scientific interest focusses on the role of indirect recognition of mismatched HLA in transplantation and on post-transplant immunomonitoring via Next Generation Sequencing of T- and B-cell receptors and immunoglobulins.
Maria P. Bettinotti – EUA
Director, Immunogenetics Laboratory.
Johns Hopkins University School of Medicine Baltimore, United States
Paul J. Martin – EUA
Dr. Paul Martin received the M.D. from the University of Pennsylvania in 1974 and completed fellowship training in Medical Oncology at the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle. He has been a Member in the Division of Clinical Research at the Fred Hutchinson Cancer Research Center and Professor of Medicine at the University of Washington since 1991. Dr. Martin has nearly 40 years of clinical and research experience in hematopoietic cell transplantation, with a particular interest in prevention and treatment of acute and chronic graft-versus-host disease.
Sujatha Krishnakumar – EUA
Sujatha Krishnakumar is the Vice President of Research and Development at Sirona Genomics, an Immucor Company. She was a co-founder of Sirona Genomics, Inc. with a team of 6 scientists from Stanford University. Sirona Genomics developed the MIA FORA NGS assay for high resolution HLA tying. She has led the Research and Development team at Sirona Genomics as its Chief Scientific Officer to commercialize the HLA typing Assay. She is currently leading a team of scientists to further develop the assay and also develop new products for diagnostics using Next Generation Sequencing.
Douglas E. Gladstone – EUA
Dr. Gladstone has been in the Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins for nearly a decade. During that time, he has been clinical director of outpatient bone marrow transplant As an allogeneic bone marrow transplant specialist, he has extensive experience with the role of allogeneic T cells and there anti-malignant potential. He published in the emerging area of Donor Specific Antibodies. He is actively involved in the study of checkpoint inhibition in the treatment of cancer. Additionally, he is well published on the treatment of severe-refractory autoimmune illnesses with high-dose chemotherapy and allogenic bone marrow transplantation.
Marcelo A. Fernandez-Vina – EUA
Professor of Pathology.
Director of Histocompatibility, Immunogenetics Disease Profiling Laboratory.
Stanford University School of Medicine
Mary Eapen – EUA
Professor, Department of Medicine
Senior Scientific Director-Research Operations, Center for International Blood and Marrow Transplant Research
Medical College of Wisconsin
Rajalingam Raja – EUA
Prof. Rajalingam is the Director of UCSF Immunogenetics and Transplantation Laboratory that provides cutting edge histocompatibility testing service for solid organ and hematopoietic stem cell transplantation. Dr. Rajalingam earned Ph.D. in Immunogenetics at the All India Institute of Medical Sciences, New Delhi in 1997. Dr. Rajalingam gained 26 years of experience in studying the basic biology and clinical implications of Histocompatibility and Immunogenetics.
Anders Fasth – EUA
Anders Fasth is professor of pediatric immunology at Dept of Pediatrics, Sahlgrenska Academy at University of Gothenburg senior consultant at the Queen Silvia Children’s Hospital, Gothenburg, Sweden. He is also consultant at Servicio de Inmunología y Reumatología Pediátrica, Hospital Nacional de Niños ‘‘Dr. Carlos Sáenz Herrera,’’ San José , Costa Rica and the Medical Director of the Swedish National Cord Blood Bank. His research focuses at primary immunodeficiency and pediatric rheumatology. Sergio Giralt, MD
Michael Pulsipher – EUA
Dr. Pulsipher joined the Children’s Hospital Los Angeles as the Head of the Section of Blood and Marrow Transplantation (BMT) and as BMT Clinical Research Chair in 2015. He is currently group chair of the Pediatric Blood and Marrow Transplant Consortium – an 80-member international clinical trials group—and is recognized as a leading influence in the field of pediatric BMT. He is currently principal or co-principal investigator on six national, multi-center studies and a co-investigator on multiple additional clinical trials. Dr. Pulsipher has authored more than 140 articles in peer-reviewed journals including Journal of Clinical Investigation, Blood, and Nature Genetics. He has also written five book chapters and presented widely at national and international conferences.
Joyce Neumann – EUA
Joyce Neumann PhD, APRN, AOCN, BMTCN received PhD in Nursing Research from Texas Woman’s
University in Houston. Received national certification by the Oncology Nursing Certification Corporation
of Oncology Nursing Society as an Advanced Oncology Certified Nursing and Blood and Marrow
Transplantation Certified Nurse. Major professional experience has been as advanced practice
registered nurse in SCT and GVHD clinic and manager of nurse practitioners as Program Director in Stem
Cell Transplantation at MDAnderson Cancer Center.
Encontro de Gerenciadores
Program Director- Data Operations
Center for International Blood Marrow Transplant Research